Sven Wischnewski has been awarded the Myositis Young Investigator Award by the German Society for Muscle Diseases for his research on inclusion body myositis. He received the award at the 27^th DGM Congress in Giessen on March 20. read more …

On 17-19 February, the MCTN hosted an exciting Innovation Bootcamp & Equality, Diversity and Inclusion Workshop at the Mannheim Medical Faculty for the students of the GLIORESOLVE project, an EU-funded research project within the Horizon Europe programme focusing on glioblastoma. read more …

Engineered T cells targeting the glioblastoma antigen PTPRZ1 show potent, selective killing of tumor cells, particularly glioblastoma stem cells, without off-target effects. In experimental brain tumors, these TCR-T cells demonstrate efficacy, persistence, and a stem-cell memory phenotype, offering a promising new strategy for glioblastoma treatment. read more …

Child and adolescent psychiatrist and psychotherapist Tobias Banaschewski of the Central Institute of Mental Health, neurologist and MCTN director Michael Platten and former MCTN co-director Rolf-Detlef Treede are among the 2024 Highly Cited Researchers! This incredible achievement reflects their dedication, expertise, and outstanding contributions to their respective fields. read more …

Thomas Kinfe has accepted an appointment as Professor for Neuromodulation and Neuroprosthetics at the Mannheim Medical Faculty of the University of Heidelberg. He is also a core member of the MCTN since October 2024. read more...

At the opening ceremony of the DGN Congress (November 6-9 in Berlin) Prof. Dr. Lucas Schirmer, Head of the Division of Neuroimmunology in the Department of Neurology at the UMM and personal core member at the MCTN, received the Science Award of the German Society of Neurology (DGN). With this award, the DGN honors Lucas Schirmer's outstanding scientific work in the field of translational neurobiology. In recent years, three of the awardee's highly published papers can be described as milestones in neuroimmunological research. read more …

An international team of researchers has investigated the composition and communication of cells in so-called subcortical lesions, tissue damage to deep brain structures at different stages of multiple sclerosis (MS). They have gained deep insights into the molecular mechanisms that influence the progression of this chronic disease. read more …